Broken Coast by Tilray Brands Now Available in Australia

The TDR Three Key Takeaways regarding Broken Coast and Tilray Brands:

  1. Tilray Brands launches Broken Coast medical cannabis brand in Australia.
  2. Expansion into Australia is focused on providing health solutions for specific patient needs, said Denise Faltischek.
  3. Broken Coast’s launch in Australia includes four different varieties of THC cannabis products.

Tilray Brands (Nasdaq: TLRY; TSX: TLRY) has introduced its Broken Coast medical cannabis brand in Australia. Tilray Brands’ entry into the Australian market is a strategic step to meet the growing demand for certified medical cannabis products.

Denise Faltischek, Chief Strategy Officer and Head of International at Tilray Brands, emphasized the significance of this expansion, stating, “Our highly scalable global footprint, which enables us to deliver medical cannabis globally from our facilities in Canada as well as our facilities in Europe, combined with our diverse portfolio of cannabis brands and products, has been instrumental in leading the evolution of the global medical cannabis industry. As medical cannabis demand continues to grow worldwide, Tilray Brands remains steadfast in our commitment to providing healthcare professionals and patients with safe and reliable access to the highest-quality medical cannabis products.”

This expansion into Australia is not just about market penetration; it is also about responding to specific patient needs. Ms. Faltischek noted, “We have been vigilant in ensuring that we continue to fulfill our mission of transforming the lives of patients by empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions. The launch of Broken Coast medical cannabis in response to the feedback we received in Australia and leveraging insights from our operations in Canada and Europe further evidences our commitment to our mission. Our unwavering dedication to innovation, quality, and patient needs continues to be the foundation upon which we build our success and growth.”

The following Broken Coast products are now available for medical cannabis patients in Australia: Broken Coast Amnesia Haze THC22 10g, Broken Coast OG Kush Breath THC25 10g, Broken Coast Cherry Cheesecake THC19 10g, and Broken Coast EmergenZ THC27 10g, which is expected to be available in July 2024. Tilray, a leading provider of EU-GMP certified medical cannabis in over 20 countries, offers a comprehensive portfolio of THC and CBD products to patients, physicians, pharmacies, hospitals, governments, and researchers worldwide. Tilray supports global medical trials studying the efficacy of medical cannabis for conditions such as pediatric epilepsy, cancer-induced nausea and vomiting, HIV, essential tremor, breast cancer disorders, post-traumatic stress disorder, and alcohol use disorders.

The launch comes at a time when the global medical cannabis market is rapidly expanding, with increasing acceptance and recognition of the therapeutic benefits of medical cannabis. Tilray Brands’ strong presence in Canada and Europe has provided a solid foundation to support its ambitions for international growth. Want to be updated on Cannabis, AI, Small Cap, and Crypto? Subscribe to our Daily Baked in Newsletter!

You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More